Cargando…
Zastosowanie Wemurafenibu w Opornej Na Leczenie Histiocytozie z Komórek Langerhansa
Langerhans Cell Histiocytosis (LCH) is a rare disease involving the occurrence of disturbances in the mitogene-activated kinases pathway (MAPK). At present, it is known that the appearance of such disorders is usually connected with a more aggressive form of the disease, more frequently resistant to...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sciendo
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522826/ https://www.ncbi.nlm.nih.gov/pubmed/30636236 http://dx.doi.org/10.34763/devperiodmed.20182204.376378 |